V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000408 | 230004946 | 1.5 | 110.6 | null | null | 2020-01-09 | Niraparib | 02 | null | NIRAPARIB | 100874156 |
| 230000480 | 230004948 | 0 | 106.2 | null | 2019-12-07 | 2019-12-15 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101844615 |
| 230000533 | 230004950 | 1.65 | 79.6 | Adjuvant (A) | null | 2021-06-29 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100809809 |
| 230000677 | 230004952 | 1.74 | 66.4 | null | 2019-12-09 | 2019-12-21 | null | null | null | CARBOPLATIN + ETOPOSIDE | 101324249 |
| 230000703 | 230004955 | 1.65 | 110.25 | null | 2019-12-23 | 2019-12-30 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101564626 |
| 230000754 | 230004956 | null | null | null | null | 2021-04-15 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101144094 |
| 230000798 | 230004959 | 1.8 | 76.7 | null | 2021-01-28 | 2021-02-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100294403 |
| 230000869 | 230004960 | 1.58 | 57.1 | Palliative (P) | null | 2020-10-22 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101278961 |
| 230000914 | 230004961 | null | null | Neo-adjuvant (N) | 2019-08-10 | 2019-08-26 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100620935 |
| 230000936 | 230004962 | null | null | Palliative (P) | 2017-03-04 | 2017-03-06 | null | null | N | OLAPARIB | 101772973 |
| 230000965 | 230004964 | 1.64 | 63.7 | Palliative (P) | null | 2019-12-14 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101177171 |
| 230001004 | 230004966 | null | null | Palliative (P) | null | 2019-10-14 | null | 01 | N | CYCLOPHOSPHAMIDE | 101112025 |
| 230001080 | 230004970 | null | null | null | 2017-03-24 | 2017-03-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101443279 |
| 230001176 | 230004971 | null | null | null | 2019-07-03 | 2019-07-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101863872 |
| 230001280 | 230004975 | null | null | null | 2018-11-07 | 2019-04-03 | Hydroxycarbamide | N | null | IPILIMUMAB + NIVOLUMAB | 100008610 |
| 230001354 | 230004979 | 1.58 | 72.4 | Palliative (P) | null | 2019-12-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100358936 |
| 230001384 | 230004981 | null | null | Palliative (P) | null | 2019-04-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101265604 |
| 230001395 | 230004982 | null | null | null | 2020-01-09 | 2020-02-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100397809 |
| 230001437 | 230004983 | 1.67 | 63.7 | null | 2020-02-12 | 2020-02-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101374920 |
| 230001448 | 230004984 | null | null | null | 2019-08-19 | 2019-09-04 | Niraparib | 02 | null | NIRAPARIB | 101207641 |
| 230001604 | 230004988 | 1.62 | null | Neo-adjuvant (N) | null | 2019-06-05 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101396281 |
| 230001623 | 230004989 | null | null | null | 2013-01-31 | 2016-03-20 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101131334 |
| 230001650 | 230004990 | 1.6 | 71.5 | Palliative (P) | 2019-05-28 | 2019-06-07 | null | 02 | N | TRIAL UNSPECIFIED | 100887276 |
| 230001657 | 230004991 | 1.59 | 61.7 | null | 2020-01-31 | 2020-02-02 | null | null | null | CISPLATIN | 101223342 |
| 230001703 | 230004992 | 1.69 | 60.9 | null | 2020-03-15 | 2021-04-17 | null | N | null | BEVACIZUMAB + CARBO + PACLITAXEL | 100273130 |
| 230001705 | 230004993 | null | null | null | 2019-07-26 | 2019-07-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100443175 |
| 230001741 | 230004994 | 1.69 | 101 | null | 2016-11-02 | 2016-11-02 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100943715 |
| 230001790 | 230004995 | 1.57 | 62 | null | null | 2019-12-11 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101252158 |
| 230001828 | 230004996 | 1.51 | 83 | Palliative (P) | 2021-03-08 | 2021-03-12 | CARBOPLATIN + ETOPOSIDE | 02 | N | TRIAL UNSPECIFIED | 100446663 |
| 230001829 | 230004997 | null | null | null | 2018-08-24 | 2018-11-16 | null | null | N | PEMBROLIZUMAB | 100408458 |
| 230001976 | 230004999 | null | null | null | null | 2020-12-13 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101770881 |
| 230002045 | 230005000 | 1.62 | 57.6 | Palliative (P) | null | 2017-12-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101121861 |
| 230002055 | 230005001 | 1.57 | 64.5 | null | 2017-01-22 | 2017-02-04 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101799681 |
| 230002111 | 230005003 | 1.57 | 55.2 | null | 2022-04-13 | 2022-04-13 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | null | TRIAL UNSPECIFIED | 101356988 |
| 230002146 | 230005005 | 1.63 | 65.2 | null | 2017-06-05 | 2017-06-21 | Olaparib | 02 | null | OLAPARIB | 100649868 |
| 230002202 | 230005008 | 1.56 | 71.3 | null | 2016-12-08 | 2016-12-22 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101517166 |
| 230002313 | 230005010 | 1.75 | 105.55 | Palliative (P) | null | 2017-12-21 | null | null | N | FLUOROURACIL + IRINOTECAN | 101541704 |
| 230000346 | 230005017 | null | null | null | 2017-06-12 | 2017-06-17 | null | 01 | null | FLUOROURACIL + IRINOTECAN | 101512272 |
| 230001178 | 230005019 | 1.68 | 55.7 | null | 2020-01-31 | 2020-01-31 | Gemcitabine day 1&8 | 02 | null | ICON8B TRIAL | 101274660 |
| 230001673 | 230005022 | 1.6 | 65.1 | null | 2018-08-12 | 2018-09-08 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101631811 |
| 230001235 | 230006013 | null | null | null | 2020-03-23 | 2020-03-24 | null | null | null | CARBOPLATIN + PACLITAXEL | 101312298 |
| 230001237 | 230006015 | null | null | null | null | 2019-11-26 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100264425 |
| 230001238 | 230006016 | null | null | null | 2020-11-21 | 2020-11-21 | null | null | null | CARBOPLATIN + PACLITAXEL | 100485250 |
| 230001239 | 230006017 | null | null | null | 2020-12-18 | 2020-12-22 | null | null | null | CARBOPLATIN + PACLITAXEL | 100839890 |
| 230001242 | 230006019 | null | null | null | null | 2021-12-13 | null | null | null | CARBOPLATIN + PACLITAXEL | 101683985 |
| 230001245 | 230006020 | null | null | null | 2017-08-04 | 2017-09-06 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100729349 |
| 230001246 | 230006021 | null | 63 | null | 2019-10-18 | 2019-11-17 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100733180 |
| 230001247 | 230006022 | null | 70.4 | null | null | 2019-10-20 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100863642 |
| 230001249 | 230006023 | 1.54 | 115 | Adjuvant (A) | null | 2019-07-28 | null | N | N | CARBOPLATIN + PACLITAXEL | 100129107 |
| 230001250 | 230006024 | null | null | null | null | 2018-12-03 | null | null | null | CARBOPLATIN + PACLITAXEL | 100436205 |